Palvella Therapeutics to debut on Nasdaq under the ticker symbol “PVLA” as a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a platform for treating ...

BofA analyst Michael Ryskin lowered the firm’s price target on Myriad Genetics (MYGN) to $13 from $15 and keeps an Underperform rating on the ...

Pokémon Trading Card Game Pocket has kicked off its Bulbasaur and Magnemite Wonder Pick Event Part 2 today, December 13, ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

For years, scientists have looked to a critical piece of immune system machinery - known as the interferon pathway - for answers. There, when our cells sense an infection, they release a protein known ...

A new study says Neanderthals and humans likely mixed and mingled during a narrow time frame 45,000 years ago.